Accordion title open

Image Description

Accordion title close

Image Description

*Mounjaro is not a weight loss drug.

Individual results may vary. In this study, the Mounjaro 5-mg, 10-mg, and 15-mg doses were compared to placebo. Study participants were also taking insulin glargine, a medication commonly associated with weight gain. Some study participants were also taking metformin. The average starting weight was between 208 to 212 pounds.

Select Safety Information

Low blood sugar (hypoglycemia). Your risk for getting low blood sugar may be higher if you use Mounjaro with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin. Signs and symptoms of low blood sugar may include dizziness or light-headedness, sweating, confusion or drowsiness, headache, blurred vision, slurred speech, shakiness, fast heartbeat, anxiety, irritability, or mood changes, hunger, weakness, and feeling jittery.

Those taking Mounjaro plus insulin glargine saw an average weight loss of 12 pounds on the 5-mg dose, 17 pounds on the 10-mg dose, and 19 pounds on the 15-mg dose. Those taking insulin glargine and placebo gained an average of 4 pounds.